Testing effectiveness (Phase 2)Study completedNCT02464163
What this trial is testing
Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older
Who this might be right for
Influenza
Protein Sciences Corporation 407